SLN
Silence Therapeutics PLC
10.70$
-2.0%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
Silence Therapeutics PLC (SLN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -62 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.7 | -1.5 | -1.8 | -1.1 | -2.9 | -2.3 | -1.8 | -2.0 | -2.5 | -2.8 | -4.0 | -3.8 | -7.0 | -4.6 | -11 | -5.1 | -4.9 | -6.8 | -9.5 | -8.3 | -10 | -9.6 | -17 | 1.7 | -11 | 9.2 | -57 | -39 | -54 | -62 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.2 | 0.4 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 0.5 | 0.6 | |
| – | – | – | – | – | – | – | – | 0.1 | 0.5 | 0.5 | 1.2 | 0.5 | 0.7 | 0.7 | 0.1 | 0.7 | 1.6 | 1.1 | 0.8 | 0.5 | 0.6 | 0.7 | 0.6 | 4.4 | 12 | 13 | 13 | 10 | 8.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1.4 | -10 | 0.3 | -0.3 | 7.5 | 6.9 | 2.8 | – | – | – | |
| 0.2 | 0.2 | -0.3 | 1.0 | -0.6 | -0.1 | -0.5 | 0.1 | 0.6 | 0.1 | -0.6 | 0.3 | -0.4 | 1.6 | -2.9 | 0.3 | 0.0 | -0.2 | 0.0 | -0.2 | -1.0 | 0.7 | -0.2 | 21 | 19 | 52 | -19 | -12 | -26 | 10 | |
| 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.5 | 0.3 | 0.2 | 0.3 | 0.3 | 0.2 | 0.1 | 0.3 | 0.9 | 0.5 | 0.2 | 0.2 | 0.0 | 0.5 | 1.8 | 0.5 | 0.0 | 0.2 | 0.1 | |
| -0.1 | 0.0 | 1.5 | -6.2 | -0.9 | 1.5 | 7.9 | 0.0 | 0.0 | -0.2 | 0.2 | 0.0 | 0.0 | -0.2 | 0.6 | -0.2 | -0.1 | -5.1 | -0.2 | 4.3 | -4.7 | 13 | -4.8 | -15 | 9.6 | 12 | -20 | 16 | -18 | -48 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.1 | 0.0 | 0.0 | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.4 | -0.4 | -0.4 | -0.4 | -0.2 | -0.2 | -0.2 | – | – | |
| 6.3 | 0.0 | 0.3 | 8.0 | 3.9 | – | – | – | 0.0 | 9.5 | 3.5 | 5.2 | 0.0 | 2.7 | 12 | 5.5 | 10 | 19 | 11 | 39 | -0.1 | 0.0 | 0.3 | 5.3 | 15 | 41 | 53 | 25 | 114 | 0.0 | |
| 5.5 | -1.5 | 0.0 | 0.7 | 0.1 | -0.8 | 5.0 | -9.2 | -2.5 | 6.5 | -0.3 | 1.4 | -6.8 | -2.2 | 2.4 | 0.1 | 5.2 | 7.0 | 1.0 | 35 | -13 | 3.7 | -21 | -8.0 | 14 | 62 | -33 | -0.8 | 42 | -110 | |
| -0.8 | -1.5 | -1.8 | -1.1 | -3.0 | -2.3 | -1.9 | -2.1 | -2.5 | -2.9 | -4.2 | -4.4 | -7.3 | -4.9 | -11 | -5.4 | -5.1 | -6.9 | -9.8 | -9.1 | -11 | -9.8 | -17 | 1.7 | -11 | 7.4 | -58 | -39 | -54 | -62 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.